Indian Drug Makers Seek Ban On Patent Evergreening Under New Regime

Law360, New York (November 28, 2004, 12:00 AM EST) -- Indian drug makers have urged the government to stamp out patent evergreening by banning the patenting of “trivial changes” to “essentially similar” molecules, as the industry braces for the introduction of product patents in January.

The Indian Pharmaceutical Alliance (IPA), which represents many of the country’s generic drug companies, has written a letter to finance minister P. Chidambaram seeking his support to preclude various new "forms" of already patented molecules from patenting, according to the Financial Express.

Allowing such patents would exceed India’s obligations under the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.